Rheumatoid Arthritis Posts on Medivizor
Navigation Menu

Rheumatoid Arthritis Posts on Medivizor

Is switching first-line targeted therapy for rheumatoid arthritis within 6 months of not reaching disease remission better than a traditional approach?

Is switching first-line targeted therapy for rheumatoid arthritis within 6 months of not reaching disease remission better than a traditional approach?

Posted by on Jul 25, 2021 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated whether switching a first-line targeted therapy (TT) within 6 months of not attaining low disease activity (LDA) enhances the chance of patients with rheumatoid arthritis (RA) achieving their target at the 12-month visit. The data showed an increased chance of achieving a target of remission or LDA at the...

Read More

Is filgotinib with background methotrexate an option for patients with rheumatoid arthritis?

Is filgotinib with background methotrexate an option for patients with rheumatoid arthritis?

Posted by on Jul 21, 2021 in Rheumatoid Arthritis | 0 comments

In a nutshell This study compared the benefit of two doses of filgotinib (Jyseleca) with adalimumab (Humira) and placebo, in patients with rheumatoid arthritis (RA) treated with methotrexate (MTX; Otrexup). The data showed that filgotinib reduced RA signs, improved physical activity, prevented structural joint damage progression, and was...

Read More

Predicting the effectiveness of certolizumab pegol in rheumatoid arthritis by serum tumor necrosis factor alpha levels after 24 hours.

Predicting the effectiveness of certolizumab pegol in rheumatoid arthritis by serum tumor necrosis factor alpha levels after 24 hours.

Posted by on Jul 11, 2021 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated the relationship between tumor necrosis factor-alpha (TNFα), interleukin (IL)-6, and serum certolizumab pegol (CZP; Cimzia) levels in patients with rheumatoid arthritis (RA) treated with CZP. The authors concluded that CZP was highly effective in patients with low serum TNFα levels at 24 hours after...

Read More

Do biological DMARDs affect fracture risk in patients with rheumatoid arthritis?

Do biological DMARDs affect fracture risk in patients with rheumatoid arthritis?

Posted by on Jun 30, 2021 in Rheumatoid Arthritis | 0 comments

In a nutshell This study analyzed the effect of using biological disease-modifying anti-rheumatic drugs (bDMARDs) on fracture risk in patients with rheumatoid arthritis (RA). The data suggest no evidence that the use of bDMARDs impacts fracture risk in these patients. Some background RA is a chronic, systemic (affects the whole body) inflammatory...

Read More

Can COVID-19 vaccines be used in patients with autoimmune rheumatic diseases?

Can COVID-19 vaccines be used in patients with autoimmune rheumatic diseases?

Posted by on Jun 13, 2021 in Rheumatoid Arthritis | 0 comments

In a nutshell This study described the guidelines from the Canadian Rheumatology Association (CRA) on the use of COVID-19 vaccines in patients with autoimmune rheumatic diseases (ARDs). The CRA recommended the use of Canada-approved COVID-19 vaccines for patients with ARDs. Some background ARDs include chronic, inflammatory conditions such as...

Read More

How effective are resistance exercises in rheumatoid arthritis treatment?

How effective are resistance exercises in rheumatoid arthritis treatment?

Posted by on May 23, 2021 in Rheumatoid Arthritis | 0 comments

In a nutshell This study reviewed the effectiveness of resistance exercise in patients with rheumatoid arthritis (RA). The data showed that resistance exercise can significantly improve disease activity in these patients. Some background RA is a progressive, autoimmune, inflammatory disease that affects multiple joints in the body. RA activity is...

Read More

Can low disease activity be achieved with a modern treatment approach in pregnant women with rheumatoid arthritis?

Can low disease activity be achieved with a modern treatment approach in pregnant women with rheumatoid arthritis?

Posted by on Apr 10, 2021 in Rheumatoid Arthritis | 0 comments

In a nutshell This study evaluated whether a modern treatment approach is suitable in patients with rheumatoid arthritis (RA) that were pregnant or intended to become pregnant. The authors concluded that low disease activity (LDA) and remission are possible with a modern approach in these women. Some background RA is an inflammatory disease....

Read More

Does smoking impact seropositivity levels in patients with rheumatoid arthritis?

Does smoking impact seropositivity levels in patients with rheumatoid arthritis?

Posted by on Apr 4, 2021 in Rheumatoid Arthritis | 0 comments

In a nutshell This study assessed the link between smoking and seropositivity levels of specific autoantibodies in patients with rheumatoid arthritis (RA). The authors concluded that patients with RA who were current smokers had significantly higher seropositivity levels than those that never smoked. Some background Smoking is an environmental risk...

Read More

Can radiographic erosion and joint space narrowing be predicted in early rheumatoid arthritis?

Can radiographic erosion and joint space narrowing be predicted in early rheumatoid arthritis?

Posted by on Mar 31, 2021 in Rheumatoid Arthritis | 0 comments

In a nutshell This study evaluated potential predictors of erosions and joint space narrowing (JSN) in patients with early rheumatoid arthritis (RA). The data showed that less JSN progression was seen in postmenopausal, overweight women with RA, and smoking was associated with JSN progression. Some background RA is an autoimmune disease that is...

Read More

Does methotrexate use increase the risk of liver fibrosis in patients with rheumatoid arthritis?

Does methotrexate use increase the risk of liver fibrosis in patients with rheumatoid arthritis?

Posted by on Mar 28, 2021 in Rheumatoid Arthritis | 0 comments

In a nutshell This study evaluated whether methotrexate use increased the presence of liver fibrosis (scarring) in patients with rheumatoid arthritis (RA). The data showed that there was no increase in the rate of liver fibrosis in patients with RA that received methotrexate. Some background RA is an inflammatory disease that affects the joints....

Read More

Baricitinib may effectively slow down progression of joint damage in patients with RA

Baricitinib may effectively slow down progression of joint damage in patients with RA

Posted by on Feb 13, 2021 in Rheumatoid Arthritis | 0 comments

In a nutshell This study reviewed the effectiveness of baricitinib (Olumiant) on the progression of structural joint damage (SJD) in patients with rheumatoid arthritis (RA). The data showed that baricitinib may significantly help slow down SJD signs found in digital imaging in patients with non-existent or insufficient...

Read More